Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$325K Buy
2,527
+704
+39% +$82.4K 0.07% 95
2026
Q1
$219K Buy
+1,823
New +$210K 0.06% 90
2024
Q2
Sell
-1,552
Closed -$205K 80
2024
Q1
$205K Buy
+1,552
New +$191K 0.07% 77
2019
Q4
Sell
-713
Closed -$57K 141
2019
Q3
$57K Buy
+713
New +$57.1K 0.05% 72

Other funds holding MRK

Atwater Malick's MRK Position: Q2 2026 in Review

Atwater Malick increased its Merck (MRK) stake by 39% in Q2 2026, buying an estimated $82.4K and bringing the position to 2,527 shares worth $325K. The position accounts for 0.07% of the portfolio, ranked #95.

Atwater Malick first reported a position in MRK in Q3 2019 and has held it in 4 quarters since. 3,819 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Atwater Malick held 2,527 shares of Merck worth $325K as of Q2 2026.
  • Atwater Malick bought 704 Merck shares in Q2 2026, an estimated $82.4K.
  • Merck made up 0.07% of Atwater Malick's portfolio in Q2 2026, its #95 holding.
  • Atwater Malick first reported a position in Merck in Q3 2019 and has held it in 4 quarters since.
  • 3,819 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Atwater Malick's 13F filing for Q2 2026, filed 27 Jul 2026.